{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:13:08Z","timestamp":1791875588079,"version":"4.3.4"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1016\/j.neuropharm.2004.06.016","type":"journal-article","created":{"date-parts":[[2004,9,14]],"date-time":"2004-09-14T18:27:23Z","timestamp":1095186443000},"page":"293-299","source":"Crossref","is-referenced-by-count":37,"special_numbering":"S1","title":["Secrets of the opium poppy revealed"],"prefix":"10.1016","volume":"47","author":[{"given":"Christopher J.","family":"Evans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2004.06.016_BIB1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev.ne.07.030184.001255","article-title":"Endogenous opioids: biology and function","volume":"7","author":"Akil","year":"1984","journal-title":"Annu. Rev. Neurosci"},{"key":"10.1016\/j.neuropharm.2004.06.016_BIB2","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.peptides.2003.08.002","article-title":"Endogenous opiates and behavior: 2002","volume":"24","author":"Bodnar","year":"2003","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2004.06.016_BIB3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1124\/mol.63.1.89","article-title":"Coexpression of delta-opioid receptors with micro receptors in GH3 cells changes the functional response to micro agonists from inhibitory to excitatory","volume":"63","author":"Charles","year":"2003","journal-title":"Mol. Pharmacol"},{"key":"10.1016\/j.neuropharm.2004.06.016_BIB4","doi-asserted-by":"crossref","first-page":"8360","DOI":"10.1523\/JNEUROSCI.23-23-08360.2003","article-title":"Brain region-specific mechanisms for acute morphine-induced mitogen-activated protein kinase modulation and distinct patterns of activation during analgesic tolerance and locomotor sensitization","volume":"23","author":"Eitan","year":"2003","journal-title":"J. Neurosci"},{"key":"10.1016\/j.neuropharm.2004.06.016_BIB5","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1126\/science.1335167","article-title":"Cloning of a \u03b4 opioid receptor by functional expression","volume":"258","author":"Evans","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2004.06.016_BIB6","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/sj.mp.4000739","article-title":"Opiate drugs: \u2018guilt by association\u2019","volume":"5","author":"Evans","year":"2000","journal-title":"Mol. Psychiatr"},{"key":"10.1016\/j.neuropharm.2004.06.016_BIB7","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1054\/npep.2002.0900","article-title":"Opioid receptor genes inactivated in mice: the highlights","volume":"36","author":"Gaveriaux-Ruff","year":"2002","journal-title":"Neuropeptides"},{"key":"10.1016\/j.neuropharm.2004.06.016_BIB8","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1002\/bies.10381","article-title":"Synapse signalling complexes and networks: machines underlying cognition","volume":"25","author":"Grant","year":"2003","journal-title":"Bioessays"},{"key":"10.1016\/j.neuropharm.2004.06.016_BIB9","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1523\/JNEUROSCI.23-10-04324.2003","article-title":"Morphine acutely regulates opioid receptor trafficking selectively in dendrites of nucleus accumbens neurons","volume":"23","author":"Haberstock-Debic","year":"2003","journal-title":"J. Neurosci"},{"key":"10.1016\/j.neuropharm.2004.06.016_BIB10","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/BF02071128","article-title":"Recent advances in molecular recognition and signal transduction of active peptides\u2014receptors for opioid peptides","volume":"15","author":"Kieffer","year":"1995","journal-title":"Cell. Mol. Neurobiol"},{"key":"10.1016\/j.neuropharm.2004.06.016_BIB11","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0092-8674(02)00666-9","article-title":"Opioid tolerance\u2014in search of the holy grail","volume":"108","author":"Kieffer","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2004.06.016_BIB12","doi-asserted-by":"crossref","first-page":"12048","DOI":"10.1073\/pnas.89.24.12048","article-title":"The \u03b4 opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization","volume":"89","author":"Kieffer","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuropharm.2004.06.016_BIB13","doi-asserted-by":"crossref","first-page":"6255","DOI":"10.1128\/MCB.23.17.6255-6266.2003","article-title":"Morphine induces desensitization of insulin receptor signaling","volume":"23","author":"Li","year":"2003","journal-title":"Mol. Cell. Biol"},{"key":"10.1016\/j.neuropharm.2004.06.016_BIB14","doi-asserted-by":"crossref","first-page":"10331","DOI":"10.1523\/JNEUROSCI.23-32-10331.2003","article-title":"Buprenorphine-induced antinociception is mediated by mu-opioid receptors and compromised by concomitant activation of opioid receptor-like receptors","volume":"23","author":"Lutfy","year":"2003","journal-title":"J. Neurosci"},{"key":"10.1016\/j.neuropharm.2004.06.016_BIB15","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0166-2236(95)93946-U","article-title":"Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications","volume":"18","author":"Mansour","year":"1995","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.neuropharm.2004.06.016_BIB16","first-page":"517","article-title":"The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog","volume":"197","author":"Martin","year":"1976","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"10.1016\/j.neuropharm.2004.06.016_BIB17","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1523\/JNEUROSCI.5569-03.2004","article-title":"Role of hippocampal CA3 micro-opioid receptors in spatial learning and memory","volume":"24","author":"Meilandt","year":"2004","journal-title":"J. Neurosci"},{"key":"10.1016\/j.neuropharm.2004.06.016_BIB18","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/cne.10839","article-title":"Phylogenetic changes in the expression of delta opioid receptors in spinal cord and dorsal root ganglia","volume":"465","author":"Mennicken","year":"2003","journal-title":"J. Comp. Neurol"},{"key":"10.1016\/j.neuropharm.2004.06.016_BIB19","first-page":"209","article-title":"Inverse agonism at adrenergic and opioid receptors: studies with wild type and constitutively active mutant receptors","volume":"5","author":"Milligan","year":"1997","journal-title":"Receptors Channels"},{"key":"10.1016\/j.neuropharm.2004.06.016_BIB20","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.tips.2004.02.005","article-title":"Historical review: molecular and cellular mechanisms of opiate and cocaine addiction","volume":"25","author":"Nestler","year":"2004","journal-title":"Trends Pharmacol. Sci"},{"key":"10.1016\/j.neuropharm.2004.06.016_BIB21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00002826-199302000-00001","article-title":"Pharmacological mechanisms of opioid analgesics","volume":"16","author":"Pasternak","year":"1993","journal-title":"Clin. Neuropharmacol"},{"key":"10.1016\/j.neuropharm.2004.06.016_BIB22","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0306-4522(98)00251-6","article-title":"Expression of mu, kappa, and delta opioid receptor messenger RNA in the human CNS: a 33P in situ hybridization study","volume":"88","author":"Peckys","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2004.06.016_BIB23","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0163-7258(01)00160-7","article-title":"G-protein-coupled receptor dimerization: modulation of receptor function","volume":"92","author":"Rios","year":"2001","journal-title":"Pharmacol. Ther"},{"key":"10.1016\/j.neuropharm.2004.06.016_BIB24","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/syn.10146","article-title":"Widespread but regionally specific effects of experimenter- versus self-administered morphine on dendritic spines in the nucleus accumbens, hippocampus, and neocortex of adult rats","volume":"46","author":"Robinson","year":"2002","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2004.06.016_BIB25","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.mcn.2003.11.003","article-title":"Modulation of extracellular signal-regulated kinases cascade by chronic Delta(9)-tetrahydrocannabinol treatment","volume":"25","author":"Rubino","year":"2004","journal-title":"Mol. Cell. Neurosci"},{"key":"10.1016\/j.neuropharm.2004.06.016_BIB26","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nrn1346","article-title":"MAPK cascade signalling and synaptic plasticity","volume":"5","author":"Thomas","year":"2004","journal-title":"Nat. Rev. Neurosci"},{"key":"10.1016\/j.neuropharm.2004.06.016_BIB27","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0959-4388(03)00069-2","article-title":"Regulated endocytosis of opioid receptors: cellular mechanisms and proposed roles in physiological adaptation to opiate drugs","volume":"13","author":"von Zastrow","year":"2003","journal-title":"Curr. Opin. Neurobiol"},{"key":"10.1016\/j.neuropharm.2004.06.016_BIB28","doi-asserted-by":"crossref","first-page":"22081","DOI":"10.1074\/jbc.274.31.22081","article-title":"Calmodulin binding to G protein-coupling domain of opioid receptors","volume":"274","author":"Wang","year":"1999","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.neuropharm.2004.06.016_BIB29","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0166-2236(83)90150-9","article-title":"Multiple endogenous ligands for opioid receptors","volume":"6","author":"Weber","year":"1983","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.neuropharm.2004.06.016_BIB30","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.2741\/1362","article-title":"Post-transcriptional regulation of opioid receptors in the nervous system","volume":"9","author":"Wei","year":"2004","journal-title":"Front. Biosci"},{"key":"10.1016\/j.neuropharm.2004.06.016_BIB31","doi-asserted-by":"crossref","first-page":"9914","DOI":"10.1073\/pnas.95.17.9914","article-title":"Morphine-activated opioid receptors elude desensitization by beta-arrestin","volume":"95","author":"Whistler","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuropharm.2004.06.016_BIB32","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1177\/107385849800400313","article-title":"ORL-1: an awkward child of the opioid receptor family","volume":"4","author":"Zaki","year":"1998","journal-title":"Neuroscientist"},{"key":"10.1016\/j.neuropharm.2004.06.016_BIB33","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1146\/annurev.pa.36.040196.002115","article-title":"Opioid receptor types and subtypes: the \u03b4 receptor as a model","volume":"36","author":"Zaki","year":"1996","journal-title":"Annu. Rev. Pharmacol. Toxicol"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390804001698?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390804001698?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T00:23:52Z","timestamp":1549239832000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390804001698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":33,"alternative-id":["S0028390804001698"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2004.06.016","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}